glucan synthase inhibitors (Pfizer)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameglucan synthase inhibitors (Pfizer)
Drug Alias Nameglucan synthase inhibitors (Pharmacia)PNU-144159E
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action1,3-beta-glucan synthase inhibitors
Targets1,3-beta-glucan synthase
Therapy Area/IndicationsMycoses
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharmacia Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer IncPharmacia Corp
Active IndicationsN/A
Inactive IndicationsMycoses

Other Information

ATC CodeN/A
Related LinksN/A